Insulin-Pump Therapy for Type 1 Diabetes Mellitus

被引:176
作者
Pickup, John C. [1 ,2 ]
机构
[1] Kings Coll London, Guys Hosp, Diabet Res Grp, London SE1 1UL, England
[2] Kings Coll London, Sch Med, Diabet Res Grp, Div Diabet & Nutr Sci, London SE1 1UL, England
关键词
MULTIPLE DAILY INJECTIONS; GLYCEMIC CONTROL; BLOOD-GLUCOSE; SEVERE HYPOGLYCEMIA; INFUSION; METAANALYSIS; CHILDREN; MANAGEMENT; VARIABILITY; POPULATION;
D O I
10.1056/NEJMct1113948
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 39-year-old man with type 1 diabetes of 27 years' duration visits his endocrinologist for review of his blood glucose control. He is overweight (body-mass index [the weight in kilograms divided by the square of the height in meters], 28.4). The overall glycemic control has been suboptimal, with glycated hemoglobin values of 7.5 to 8.0% in recent years. He reports unpredictable swings in self-monitored blood glucose concentrations and frequent episodes of severe hypoglycemia, which markedly disrupt his work and home life. He also reports that he now has fewer warning symptoms of hypoglycemia than he had previously. These findings are present despite the patient's best efforts to achieve glycemic control with intensified insulin-injection therapy, regular visits to a diabetes clinic, and input from diabetes nurse educators. He attended a structured diabetes education course 1 year previously, which he found to be useful and which led to slight improvements in glycated hemoglobin levels; however, the frequency of hypoglycemic episodes was unchanged. His endocrinologist has ruled out coexisting illnesses, including celiac disease and Addison's disease, as causes of poor glycemic control and wonders whether a trial of insulin-pump therapy is appropriate. Since the endocrinologist has little experience with this type of therapy himself, he refers the patient to a center with a specialized insulin-pump clinic.
引用
收藏
页码:1616 / 1624
页数:9
相关论文
共 50 条
[1]   Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial [J].
Amiel, S ;
Beveridge, S ;
Bradley, C ;
Gianfrancesco, C ;
Heller, S ;
James, P ;
McKeown, N ;
Newton, D ;
Newton, L ;
Oliver, L ;
Reid, H ;
Roberts, S ;
Robson, S ;
Rollingson, J ;
Scott, V ;
Speight, J ;
Taylor, C ;
Thompson, G ;
Turner, E ;
Wright, F .
BRITISH MEDICAL JOURNAL, 2002, 325 (7367) :746-749
[2]  
[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004]
[3]  
[Anonymous], OXFORD TXB ENDOCRINO
[4]  
[Anonymous], DIABETES RES CL 1228
[5]  
[Anonymous], 2005, PRACT DIABET INT
[6]  
[Anonymous], INSULIN PUMP THERAPY
[7]  
[Anonymous], DIABETES ED
[8]  
[Anonymous], 2008, CONT SUBC INS INF TR
[9]  
[Anonymous], 2009, PRACT DIABETES INT, DOI DOI 10.1002/PDI.1324
[10]   Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention [J].
Borus, Joshua S. ;
Laffel, Lori .
CURRENT OPINION IN PEDIATRICS, 2010, 22 (04) :405-411